Alpha 0.1.0

Biotech411

Biotechnology. Right now.

Biologics milestone tracker

Clinical trial milestones and FDA decisions, linked by program and indication.

Tracked records

Rybrevant Faspro · head and neck cancer

OrigAMI-4 examined amivantamab in head and neck cancer. FDA based the new indication on a group of 102 previously treated patients.

View timeline (2)

Jemperli · rectal cancer

AZUR-1 enrolled patients with previously untreated stage II or III locally advanced rectal cancer with MSI-high or mismatch-repair-deficient tumors.

View timeline (3)

Genglycos · glycogen storage disease Ia

The DTX401 phase 3 study measured daily cornstarch use. FDA required further evidence of clinical benefit after accelerated approval.

View timeline (4)

Fayuvi · Sanfilippo syndrome type A

Study NCT02716246 was one of three records FDA cited in its review of Fayuvi for children with preserved neurodevelopmental function.

View timeline (2)